Augmenting immunity with exogeneous cytokines has been attempted in HIV infection; and although CD4 T cell numbers were increased with administration of IL-2, two large clinical trials failed to show any evidence of clinical benefit [38]. Here, IL2 is linked to HIV infectious disease.